Parallel Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.6K | Sell |
803
-417
| -34% | -$10.2K | ﹤0.01% | 2198 |
|
|
2025
Q1 | $25.3K | Buy |
1,220
+422
| +53% | +$8.76K | ﹤0.01% | 2003 |
|
|
2024
Q4 | $18.8K | Hold |
798
| – | – | ﹤0.01% | 2152 |
|
|
2024
Q3 | $20.4K | Buy |
798
+753
| +1,673% | +$19.3K | ﹤0.01% | 2072 |
|
|
2024
Q2 | $1.06K | Sell |
45
-105
| -70% | -$2.47K | ﹤0.01% | 2926 |
|
|
2024
Q1 | $4.31K | Buy |
150
+30
| +25% | +$863 | ﹤0.01% | 2573 |
|
|
2023
Q4 | $3.94K | Hold |
120
| – | – | ﹤0.01% | 2590 |
|
|
2023
Q3 | $3.34K | Hold |
120
| – | – | ﹤0.01% | 2644 |
|
|
2023
Q2 | $4.09K | Hold |
120
| – | – | ﹤0.01% | 2500 |
|
|
2023
Q1 | $3.61K | Sell |
120
-10
| -8% | -$301 | ﹤0.01% | 2539 |
|
|
2022
Q4 | $3.67K | Hold |
130
| – | – | ﹤0.01% | 2458 |
|
|
2022
Q3 | $4K | Sell |
130
-65
| -33% | -$2K | ﹤0.01% | 2340 |
|
|
2022
Q2 | $6K | Sell |
195
-166
| -46% | -$5.11K | ﹤0.01% | 2144 |
|
|
2022
Q1 | $17K | Sell |
361
-227
| -39% | -$10.7K | ﹤0.01% | 1782 |
|
|
2021
Q4 | $36K | Buy |
588
+14
| +2% | +$857 | ﹤0.01% | 1500 |
|
|
2021
Q3 | $43K | Sell |
574
-501
| -47% | -$37.5K | ﹤0.01% | 1319 |
|
|
2021
Q2 | $99K | Buy |
1,075
+178
| +20% | +$16.4K | ﹤0.01% | 938 |
|
|
2021
Q1 | $80K | Buy |
897
+681
| +315% | +$60.7K | ﹤0.01% | 967 |
|
|
2020
Q4 | $20K | Buy |
216
+43
| +25% | +$3.98K | ﹤0.01% | 1449 |
|
|
2020
Q3 | $11K | Buy |
+173
| New | +$11K | ﹤0.01% | 1663 |
|